Drug-coating Balloon Treatment in Coronary Artery Disease

  • STATUS
    Recruiting
  • End date
    Dec 30, 2030
  • participants needed
    3000
  • sponsor
    Nanjing First Hospital, Nanjing Medical University
Send
Updated on 19 February 2024
See if I qualify
arterial disease

Summary

Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.

Description

This is a prospective, multi-center, registry to enroll patients undergoing DCB treatment.

All subjects undergoing DCB treatment will be enrolled in this study without strict inclusion and exclusion criteria. Data and images will be collected during the index procedure, and at the clinical and angiographic follow-up.

Details
Condition Coronary Artery Disease, Coronary Artery Disease, Coronary heart disease
Age 18years - 100years
Treatment DCB treatment
Clinical Study IdentifierNCT04255563
SponsorNanjing First Hospital, Nanjing Medical University
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patients suitable for DCB treatment

Exclusion Criteria

Pregnancy
Contraindications to contrast media, antiplatelet therapy, or paclitaxel
Expected life less than 12 months
Cardiac shock
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

arterial disease

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.